CD274 and breast carcinoma: A recent breast cancer study showed that B cells suppressed the antitumor immune response in tumor-bearing mice by expressing LAP/TGF-β and PD-L1, markedly reducing CD8+ T cell and CD49+ NK cell infiltration, and reducing cytolytic T cell response [22].